WHO Consults On Evaluating mRNA Vaccines For Infectious Diseases
Special Considerations Outlined For COVID-19 Vaccines
Executive Summary
The World Health Organization says there is a pressing need for guidance on the evaluation of mRNA vaccines because of the rapidity with which clinical trials have progressed for COVID-19 candidate vaccines, their emergency use approval or authorization, and their subsequent widespread use.